The roles of prostanoids, leukotrienes, and platelet-activating factor in bone metabolism and disease.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Progress in lipid research

• Publication date

  2008-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.plipres.2007.12.003PMID 18187046
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular and cellular mechanisms of the anabolic effect of intermittent PTH.

  2007influential reference
• An update on glucocorticoid-induced osteoporosis

  2007cited by this paper
• Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine.

  2007cited by this paper
• Cysteinyl‐leukotrienes and their receptors in asthma and other inflammatory diseases: Critical update and emerging trends

  2007influential reference
• A Single Enzyme Catalyzes Both Platelet-activating Factor Production and Membrane Biogenesis of Inflammatory Cells

  2007cited by this paper
• Activation of PKA and phosphorylation of sodium-dependent vitamin C transporter 2 by prostaglandin E2 promote osteoblast-like differentiation in MC3T3-E1 cells

  2007cited by this paper
• Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways.

  2007cited by this paper
• Neutrophil-derived leukotriene B4 is required for inflammatory arthritis

  2006cited by this paper
• Targeted Disruption of Leukotriene B4 Receptors BLT1 and BLT2: A Critical Role for BLT1 in Collagen-Induced Arthritis in Mice1

  2006cited by this paper
• Membrane-Bound Prostaglandin E Synthase-1-Mediated Prostaglandin E2 Production by Osteoblast Plays a Critical Role in Lipopolysaccharide-Induced Bone Loss Associated with Inflammation

  2006cited by this paper
• Role of Cbfa1/Runx2 in the fluid shear stress induction of COX-2 in osteoblasts.

  2006cited by this paper
• Osteoclasts, rheumatoid arthritis, and osteoimmunology

  2006cited by this paper
• A unique requirement for the leukotriene B4 receptor BLT1 for neutrophil recruitment in inflammatory arthritis

  2006cited by this paper
• Monitoring osteoporosis therapy: bone mineral density, bone turnover markers, or both?

  2006cited by this paper
• Effects of selective prostaglandins E2 receptor agonists on cultured calvarial murine osteoblastic cells.

  2006cited by this paper
• Prostaglandin D2 pathway and peroxisome proliferator-activated receptor gamma-1 expression are induced by mechanical loading in an osteoblastic cell line.

  2006influential reference
• Prostacyclin-IP signaling and prostaglandin E2-EP2/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis

  2006influential reference
• Inhibitors of cyclo-oxygenase-2 and secretory phospholipase A2 preserve bone architecture following ovariectomy in adult rats.

  2006cited by this paper
• Biochemical properties and pathophysiological roles of cytosolic phospholipase A2s.

  2006cited by this paper
• Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis subgingival presence, species-specific serum immunoglobulin G antibody levels, and periodontitis disease recurrence.

  2006cited by this paper
• Attenuation of folic acid-induced renal inflammatory injury in platelet-activating factor receptor-deficient mice.

  2006cited by this paper
• Bone Biomechanical Properties in EP4 Knockout Mice

  2006cited by this paper
• Local application of prostaglandin E2 reduces trap, calcitonin receptor and metalloproteinase-2 immunoreactivity in the rat periodontium.

  2005cited by this paper
• Disease progression: identification of high-risk groups and individuals for periodontitis.

  2005cited by this paper
• Expression of PPARgamma and beta/delta in human primary osteoblastic cells: influence of polyunsaturated fatty acids.

  2005cited by this paper
• IL-1-induced receptor activator of NF-kappa B ligand in human periodontal ligament cells involves ERK-dependent PGE2 production.

  2005cited by this paper
• PGE2 induces the gene expression of bone matrix metalloproteinase-1 in mouse osteoblasts by cAMP-PKA signaling pathway.

  2005cited by this paper
• A Nonprostanoid EP4 Receptor Selective Prostaglandin E2 Agonist Restores Bone Mass and Strength in Aged, Ovariectomized Rats

  2005influential reference
• LTB4 Can Directly Stimulate Human Osteoclast Formation from PBMC Independent of RANKL

  2005cited by this paper
• Prostaglandins: Mechanisms of action and regulation of production in bone

  2005cited by this paper
• Prostaglandins differently regulate FGF-2 and FGF receptor expression and induce nuclear translocation in osteoblasts via MAPK kinase

  2005influential reference
• Effects of antirheumatic treatments on the prostaglandin E2 biosynthetic pathway.

  2005cited by this paper
• Expression of PPARγ and β/δ in Human Primary Osteoblastic Cells: Influence of Polyunsaturated Fatty Acids

  2005cited by this paper
• Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-{kappa}B (RANK) ligand/RANK system.

  2005cited by this paper
• IL-1 alpha stimulates the formation of osteoclast-like cells by increasing M-CSF and PGE2 production and decreasing OPG production by osteoblasts.

  2005cited by this paper
• Osteopenia and impaired fracture healing in aged EP4 receptor knockout mice.

  2005influential reference
• Prostaglandin E2 strongly inhibits human osteoclast formation.

  2005influential reference
• Leukotriene and prostaglandin synthesis pathways in osteoarthritic synovial membranes: regulating factors for interleukin 1beta synthesis.

  2005cited by this paper
• Prostaglandin E2 Enhances Osteoclastic Differentiation of Precursor Cells through Protein Kinase A-dependent Phosphorylation of TAK1*

  2005cited by this paper
• Prostaglandin E2 Receptors EP2 and EP4 Are Down-regulated during Differentiation of Mouse Osteoclasts from Their Precursors*

  2005influential reference
• Prostaglandin E2 Stimulates Fibronectin Expression through EP1 Receptor, Phospholipase C, Protein Kinase Cα, and c-Src Pathway in Primary Cultured Rat Osteoblasts*

  2005cited by this paper
• Biochemistry, biology and chemistry of the 5-lipoxygenase product 5-oxo-ETE.

  2005cited by this paper
• Cyclooxygenases, peroxide tone and the allure of fish oil.

  2005influential reference
• Pathogenesis of osteoporosis: concepts, conflicts, and prospects.

  2005cited by this paper
• Bio-adhesive Surfaces to Promote Osteoblast Differentiation and Bone Formation

  2005cited by this paper
• Dual phase regulation of experimental allergic encephalomyelitis by platelet-activating factor

  2005cited by this paper
• Platelet-Activating Factor Receptor Develops Airway Hyperresponsiveness Independently of Airway Inflammation in a Murine Asthma Model1

  2004cited by this paper
• Vitamin D and bone

  2004influential reference
• Prostaglandin E2 enhances alveolar bone formation in the rat mandible.

  2004cited by this paper
• IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology.

  2004cited by this paper
• Inhibition of leukotriene B4-induced CD11B/CD18 (Mac-1) expression by BIIL 284, a new long acting LTB4 receptor antagonist, in patients with rheumatoid arthritis

  2004cited by this paper
• Possible involvement of p38 MAP kinase in prostaglandin E1-induced ALP activity in osteoblast-like cells.

  2004cited by this paper
• PGE2 induces IL-1beta gene expression in mouse osteoblasts through a cAMP-PKA signaling pathway.

  2004cited by this paper
• Suppression of Osteoprotegerin Expression by Prostaglandin E2 Is Crucially Involved in Lipopolysaccharide-Induced Osteoclast Formation1

  2004influential reference
• Involvement of SAPK/JNK in prostaglandin E(1)-induced VEGF synthesis in osteoblast-like cells.

  2004cited by this paper
• Extracellular calcium induces COX-2 in osteoblasts via a PKA pathway.

  2004cited by this paper
• Role of EP3 and EP4 prostaglandin receptors in reorganization of the cytoskeleton in mature human osteoclasts.

  2004influential reference
• Absence of platelet-activating factor receptor protects mice from osteoporosis following ovariectomy.

  2004influential reference
• Reduced Pain Hypersensitivity and Inflammation in Mice Lacking Microsomal Prostaglandin E Synthase-1*

  2004cited by this paper
• Stimulation of cAMP production and cyclooxygenase-2 by prostaglandin E(2) and selective prostaglandin receptor agonists in murine osteoblastic cells.

  2004influential reference
• Sesquiterpene Lactone Parthenolide Blocks Lipopolysaccharide‐Induced Osteolysis Through the Suppression of NF‐κB Activity

  2004influential reference
• Immunolocalization of the prostaglandin E2 receptor subtypes in human bone tissue: differences in foetal, adult normal, osteoporotic and pagetic bone.

  2004cited by this paper
• Regulation of bone morphogenetic protein‐2 expression by endogenous prostaglandin E2 in human mesenchymal stem cells

  2004cited by this paper
• Production of Prostaglandin D2 by Human Osteoblasts and Modulation of Osteoprotegerin, RANKL, and Cellular Migration by DP and CRTH2 Receptors

  2004influential reference
• Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice.

  2004cited by this paper
• Formation of focal adhesions on fibronectin promotes fluid shear stress induction of COX-2 and PGE2 release in MC3T3-E1 osteoblasts.

  2004cited by this paper
• IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology.

  2004cited by this paper
• Osteoarthritis, genetic and molecular mechanisms

  2004cited by this paper
• Lipopolysaccharide stimulates expression of osteoprotegerin and receptor activator of NF-kappa B ligand in periodontal ligament fibroblasts through the induction of interleukin-1 beta and tumor necrosis factor-alpha.

  2004cited by this paper
• Differential inhibition of fracture healing by non‐selective and cyclooxygenase‐2 selective non‐steroidal anti‐inflammatory drugs

  2003cited by this paper
• Vitamin D and bone

  2003cited by this paper
• Prevention and management of osteoporosis

  2003cited by this paper
• A Novel, Non‐Prostanoid EP2 Receptor‐Selective Prostaglandin E2 Agonist Stimulates Local Bone Formation and Enhances Fracture Healing

  2003cited by this paper
• Stimulatory effect of prostaglandin F(2alpha) on Na-dependent phosphate transport in osteoblast-like cells.

  2003cited by this paper
• An Essential Role of Cytosolic Phospholipase A2α in Prostaglandin E2–mediated Bone Resorption Associated with Inflammation

  2003cited by this paper
• Role of eicosanoids in structural degradation in osteoarthritis

  2003cited by this paper
• Cloning of the cDNA for human 5-lipoxygenase (leukotrienes/transcriptional regulation/differentiation/HL60 cells)

  2003cited by this paper
• Treatment with licofelone prevents abnormal subchondral bone cell metabolism in experimental dog osteoarthritis

  2003cited by this paper
• Regulation of the osteoblast‐specific transcription factor, Runx2: Responsiveness to multiple signal transduction pathways

  2003cited by this paper
• Cyclooxygenase-2 and prostaglandins in articular tissues.

  2003cited by this paper
• Prostaglandin E2 Stimulates Bone Sialoprotein (BSP) Expression through cAMP and Fibroblast Growth Factor 2 Response Elements in the Proximal Promoter of the Rat BSP Gene*

  2003cited by this paper
• Incadronate Amplifies Prostaglandin F2α-induced Vascular Endothelial Growth Factor Synthesis in Osteoblasts

  2003influential reference
• Experimental Trypanosoma cruzi infection in platelet-activating factor receptor-deficient mice.

  2003cited by this paper
• Cytosolic Phospholipase A 2 (cid:2) –deficient Mice Are Resistant to Collagen-induced Arthritis

  2003cited by this paper
• Requisite roles of Runx2 and Cbfb in skeletal development

  2003cited by this paper
• Role of PAF receptors during intestinal ischemia and reperfusion injury. A comparative study between PAF receptor‐deficient mice and PAF receptor antagonist treatment

  2003cited by this paper
• Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase

  2003cited by this paper
• The menopause and HRT. Prevention and management of osteoporosis.

  2003cited by this paper
• The Mechanisms of the Inhibitory Effects of Nonsteroidal Anti‐Inflammatory Drugs on Bone Healing: A Concise Review

  2003cited by this paper
• Extracellular Calcium Is a Potent Inducer of Cyclo‐oxygenase‐2 in Murine Osteoblasts Through an ERK Signaling Pathway

  2003cited by this paper
• Dietary n‐3 Fatty Acids Decrease Osteoclastogenesis and Loss of Bone Mass in Ovariectomized Mice

  2003cited by this paper
• An EP2 receptor-selective prostaglandin E2 agonist induces bone healing

  2003cited by this paper
• Transactivation of the epidermal growth factor receptor mediates parathyroid hormone and prostaglandin F2 alpha-stimulated mitogen-activated protein kinase activation in cultured transgenic murine osteoblasts.

  2003influential reference
• Association Between Bone Mineral Density and the Use of Nonsteroidal Anti‐Inflammatory Drugs and Aspirin: Impact of Cyclooxygenase Selectivity

  2003cited by this paper
• Role of the platelet‐activating factor (PAF) receptor during pulmonary infection with gram negative bacteria

  2002cited by this paper
• Prostaglandin receptor EP2 mediates PGE2 stimulated hypercalcemia in mice in vivo.

  2002cited by this paper
• Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants.

  2002cited by this paper
• Effects of prostaglandin E2 on gene expression in primary osteoblastic cells from prostaglandin receptor knockout mice.

  2002cited by this paper
• The role of growth factors in the repair of bone. Biology and clinical applications.

  2002cited by this paper
• Identification of a Novel Human Eicosanoid Receptor Coupled to Gi/o *

  2002cited by this paper

• PGE2 Ameliorates Aging-Aggravated Rotator Cuff Muscle Atrophy.

  2025cites this paper
• The Mechanism Exploration of Traditional Chinese Medicine's “Different Treatments for Same Disease” Concept in Osteoporosis Therapy: A Serum Metabolomics Study

  2025cites this paper
• Extracellular vimentin amplifies inflammation: Perspectives for immune injury and therapeutics for periodontitis

  2025cites this paper
• Regulation of osteoclast-mediated bone resorption by lipids.

  2025cites this paper
• The Interplay of Lipid Signaling in Musculoskeletal Cross Talk: Implications for Health and Disease.

  2024cites this paper
• Gallein but not fluorescein enhances the PGD2-stimulated synthesis of osteoprotegerin and interleukin-6 in osteoblasts: Amplification of osteoprotegerin/interleukin-6 by gallein.

  2024cites this paper
• Cytokines profile in gingival crevicular fluid of subjects wearing fixed dental prostheses: a systematic review and meta-analysis

  2024cites this paper
• Gallein increases prostaglandin F2α‑induced osteoprotegerin and IL‑6 secretion in osteoblasts.

  2024cites this paper
• Market Needs and Methodologies Associated with Patient Lipidomic Diagnoses and Analyses.

  2024cites this paper
• Urinary prostanoids are elevated by anti-TNF and anti-IL6 receptor disease-modifying antirheumatic drugs but are not predictive of response to treatment in early rheumatoid arthritis

  2024cites this paper
• Oncostatin M suppresses bone morphogenetic protein‐4‐induced osteoprotegerin synthesis in MC3T3‐E1 osteoblast‐like cells: p70 S6 kinase attenuation

  2024cites this paper
• Exploring Omega-3′s Impact on the Expression of Bone-Related Genes in Meagre (Argyrosomus regius)

  2023cites this paper
• Effect of endothelin-1 on cyclooxygenase-2 gene expression and prostaglandin E2 synthesis in human periodontal fibroblasts

  2023influential citation
• Oncostatin M stimulates prostaglandin D2-induced osteoprotegerin and interleukin-6 synthesis in osteoblasts.

  2023cites this paper
• Revisiting Resveratrol as an Osteoprotective Agent: Molecular Evidence from In Vivo and In Vitro Studies

  2023cites this paper
• The Multifarious Functions of Leukotrienes in Bone Metabolism

  2023influential citation
• Factors secreted by monosodium urate crystal-stimulated macrophages promote a proinflammatory state in osteoblasts: a potential indirect mechanism of bone erosion in gout

  2022cites this paper
• Incretins Enhance PGF2α-Induced Synthesis of IL-6 and Osteoprotegerin in Osteoblasts.

  2022cites this paper
• Modulation of Inflammatory Responses by a Non-Invasive Physical Plasma Jet during Gingival Wound Healing

  2022cites this paper
• HSP70 inhibitors upregulate prostaglandin E1-induced synthesis of interleukin-6 in osteoblasts

  2022cites this paper
• An inhibitor of leukotriene-A4 hydrolase from bat salivary glands facilitates virus infection

  2022cites this paper
• Stem Cells to Decipher the Physiological Roles of 5-HT2B Receptor Signaling

  2021cites this paper
• 15d-PGJ2 Promotes ROS-Dependent Activation of MAPK-Induced Early Apoptosis in Osteosarcoma Cell In Vitro and in an Ex Ovo CAM Assay

  2021cites this paper
• Amplification by tramadol of PGD2-induced osteoprotegerin synthesis in osteoblasts: Involvement of μ-opioid receptor and 5-HT transporter.

  2021cites this paper
• Acetaminophen reduces osteoprotegerin synthesis stimulated by PGE2 and PGF2α in osteoblasts: attenuation of SAPK/JNK but not p38 MAPK or p44/p42 MAPK.

  2021cites this paper
• Filifactor alocis and Tumor Necrosis Factor-Alpha Stimulate Synthesis of Visfatin by Human Macrophages

  2021cites this paper
• Crosstalk between the COX2‐PGE2‐EP4 signaling pathway and primary cilia in osteoblasts after mechanical stimulation

  2020cites this paper
• SQSTM1-dependent autophagic degradation of PKM2 inhibits the production of mature IL1B/IL-1β and contributes to LIPUS-mediated anti-inflammatory effect

  2020cites this paper
• Regulation of Cyclooxygenase 2 by Filifactor alocis in Fibroblastic and Monocytic Cells

  2020cites this paper
• Duloxetine strengthens osteoblast activation by prostaglandin E1: Upregulation of p38 MAP kinase.

  2020cites this paper
• Tramadol enhances PGF2α-stimulated osteoprotegerin synthesis in osteoblasts

  2020cites this paper
• Investigation of Antibacterial and Antiinflammatory 2 Activities of Proanthocyanidins from Pelargonium 3 Sidoides DC Root Extract 4

  2019cites this paper
• Enhancement by HSP90 inhibitor of PGD2-stimulated HSP27 induction in osteoblasts: Suppression of SAPK/JNK and p38 MAP kinase.

  2019cites this paper
• Investigation of Antibacterial and Antiinflammatory Activities of Proanthocyanidins from Pelargonium sidoides DC Root Extract

  2019cites this paper
• Serotonin in stem cell based-dental repair and bone formation: A review.

  2019cites this paper
• Long-term administration of fenspiride has no negative impact on bone mineral density and bone turnover in young growing rats.

  2019cites this paper
• Montelukast inhibits RANKL‑induced osteoclast formation and bone loss via CysLTR1 and P2Y12.

  2018cites this paper
• Sauchinone prevents IL‐1β‐induced inflammatory response in human chondrocytes

  2018cites this paper
• 1 Osteo-Protective Effect of Curcumin , Fenugreek and their Combination on Ovariectomized Female Rats

  2018cites this paper
• Pharmacological characterisation of CR6086, a potent prostaglandin E2 receptor 4 antagonist, as a new potential disease-modifying anti-rheumatic drug

  2018cites this paper
• Discovery of {4-[4,9-bis(ethyloxy)-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl]-2-fluorophenyl}acetic acid (GSK726701A), a novel EP4 receptor partial agonist for the treatment of pain.

  2018cites this paper
• Prostaglandins and Other Lipid Mediators-)-Epigallocatechin gallate synergistically potentiates prostaglandin 2-stimulated osteoprotegerin synthesis in osteoblasts

  2017cites this paper
• The role of 5‐lipoxygenase in Aggregatibacter actinomycetemcomitans‐induced alveolar bone loss

  2017cites this paper
• (-)-Epigallocatechin gallate synergistically potentiates prostaglandin E2-stimulated osteoprotegerin synthesis in osteoblasts.

  2017cites this paper
• Amplification by (‑)‑epigallocatechin gallate of prostaglandin F2α‑stimulated synthesis of osteoprotegerin in osteoblasts.

  2017cites this paper
• Attenuation of prostaglandin E1‑induced osteoprotegerin synthesis in osteoblasts by normoxic HIF inducers.

  2017cites this paper
• Porphyromonas gingivalis gingipains cause defective macrophage migration towards apoptotic cells and inhibit phagocytosis of primary apoptotic neutrophils

  2017cites this paper
• Activation of the MAPK/Akt/Nrf2-Egr1/HO-1-GCLc axis protects MG-63 osteosarcoma cells against 15d-PGJ2-mediated cell death

  2016cites this paper
• Regulation by AMP-activated protein kinase of PGE2-induced osteoprotegerin synthesis in osteoblasts.

  2016cites this paper
• Mimosine suppresses the PGF2α-induced synthesis of osteoprotegerin but not interleukin-6 in osteoblasts.

  2016cites this paper
• Possible involvement of AMP-activated protein kinase in PGE1-induced synthesis of osteoprotegerin in osteoblasts.

  2016cites this paper
• Pros and cons of fatty acids in bone biology.

  2015cites this paper
• Resveratrol reduces prostaglandin E1-stimulated osteoprotegerin synthesis in osteoblasts: suppression of stress-activated protein kinase/c-Jun N-terminal kinase.

  2015cites this paper
• PGD2 stimulates osteoprotegerin synthesis via AMP-activated protein kinase in osteoblasts: Regulation of ERK and SAPK/JNK.

  2015cites this paper
• Роль цитокиновой системы rankl-rank-opg и катепсина к в патогенезе остеопороза: достижения и перспективы в лечении заболевания

  2015cites this paper
• Gene expression profiling in periodontitis

  2015cites this paper
• Suppression by resveratrol of prostaglandin D2-stimulated osteoprotegerin synthesis in osteoblasts.

  2014cites this paper
• The role of leukotrienes in immunopathogenesis of rheumatoid arthritis

  2014cites this paper
• Periodontal Disease in Mice actinomycetemcomitans-Induced Blockade Ameliorates Aggregatibacter Platelet-Activating Factor Receptor

  2014cites this paper
• Red light as a 12-oxo-leukotriene B4 antagonist: an explanation for the efficacy of intensive red light in the therapy of peripheral inflammatory diseases

  2014cites this paper
• Amphotericin B down-regulates Aggregatibacter actinomycetemcomitans-induced production of IL-8 and IL-6 in human gingival epithelial cells.

  2014cites this paper
• TDAG8 activation inhibits osteoclastic bone resorption

  2014cites this paper
• Interrelationship among muscle, fat, and bone: connecting the dots on cellular, hormonal, and whole body levels.

  2014cites this paper
• The relevance of leukotrienes for bone resorption induced by mechanical loading.

  2014cites this paper
• The nitric oxide-mediated regulation of prostaglandin signaling in medicine.

  2014cites this paper
• The role of polyunsaturated ω-3 fatty acid eicosapentaenoic acid-derived resolvin E1 (RvE1) in bone preservation.

  2014cites this paper
• Inflammatory mediators in the pathogenesis of periodontitis

  2013cites this paper
• The Prostanoid EP4 Receptor and Its Signaling Pathway

  2013cites this paper
• Metabonomic profiling in studying anti-osteoporosis effects of strontium fructose 1,6-diphosphate on estrogen deficiency-induced osteoporosis in rats by GC/TOF-MS.

  2013cites this paper
• Platelet-Activating Factor Receptor Blockade Ameliorates Aggregatibacter actinomycetemcomitans-Induced Periodontal Disease in Mice

  2013cites this paper
• Phospholipases of Mineralization Competent Cells and Matrix Vesicles: Roles in Physiological and Pathological Mineralizations

  2013cites this paper
• Response of human bone marrow stromal cells, MG-63, and SaOS-2 to titanium-based dental implant surfaces with different topography and surface energy.

  2013cites this paper
• A Special Ingredient (VtR) Containing Oligostilbenes Isolated from Vitis thunbergii Prevents Bone Loss in Ovariectomized Mice: In Vitro and In Vivo Study

  2013cites this paper
• The role of leukotrienes in immunopathogenesis of rheumatoid arthritis

  2013cites this paper
• O papel dos metabólitos da via 5-lipoxigenase na remodelação óssea induzida por força mecânica

  2013cites this paper
• Resolvin E1 regulates osteoclast fusion via DC‐STAMP and NFATc1

  2013cites this paper
• THE ROLE OF CYTOKINE SYSTEM RANKL-RANK-OPG AND CATHEPSIN K IN THE PATHOGENESIS OF OSTEOPOROSIS: ACHIEVEMENTS AND PERSPECTIVES IN THE TREATMENT OF DISEASE

  2012cites this paper
• Gs-[alpha] in osteoblasts regulates bone formation and osteoblast differentiation

  2012cites this paper
• UNIVERSIDADE DE SÃO PAULO FACULDADE DE ODONTOLOGIA DE RIBEIRÃO PRETO

  2012cites this paper
• Wnt3a upregulates prostaglandin F2α-stimulated vascular endothelial growth factor synthesis in osteoblasts.

  2012cites this paper
• A potential role of chondroitin sulfate on bone in osteoarthritis: inhibition of prostaglandin E₂ and matrix metalloproteinases synthesis in interleukin-1β-stimulated osteoblasts.

  2012cites this paper
• Up-Regulation of the Inflammatory Response by Ovariectomy in Collagen-Induced Arthritis. Effects of Tin Protoporphyrin IX

  2011cites this paper
• Evaluation of the Anti-Inflammatory Effects of Novel Pirinixic Acid Derivatives

  2011cites this paper
• Influence of anti‐inflammatory administration in collagen maturation process during orthodontic tooth movement

  2011cites this paper
• Effects of long-term administration of carprofen on healing of a tibial osteotomy in dogs.

  2011cites this paper
• Effects of Typheramide and Alfrutamide Found in Allium Species on Cyclooxygenases and Lipoxygenases

  2011cites this paper
• Peripheral kappa opioid receptors activation reduces alveolar bone loss in rats by modulating interleukin-6 and -10.

  2011cites this paper
• Prostaglandin E synthases in periodontitis-affected gingival tissue and in gingival fibroblasts

  2011cites this paper
• Inflammation and Uncoupling as Mechanisms of Periodontal Bone Loss

  2011cites this paper
• The novel phospho‐non‐steroidal anti‐inflammatory drugs, OXT‐328, MDC‐22 and MDC‐917, inhibit adjuvant‐induced arthritis in rats

  2011cites this paper
• Serotonergic 5-HT2B Receptor Controls Tissue-nonspecific Alkaline Phosphatase Activity in Osteoblasts via Eicosanoids and Phosphatidylinositol-specific Phospholipase C*

  2010cites this paper
• Differential effect of chondroitin-4-sulfate on the immediate and delayed prostaglandin E2 release from osteoblasts.

  2010cites this paper
• Polarized Light Microscopic Analysis of Bone Formation After Inhibition of Cyclooxygenase 1 and 2

  2010cites this paper
• Rho-kinase regulates prostaglandin D(2)-stimulated heat shock protein 27 induction in osteoblasts.

  2010cites this paper
• Circulating osteogenic cells: characterization and relationship to rates of bone loss in postmenopausal women.

  2010cites this paper
• Pharmacological characterization of anaphylaxis-like shock responses induced in mice by mannan and lipopolysaccharide.

  2009cites this paper
• Involvement of Rho-kinase in prostaglandin E(1)-stimulated VEGF synthesis through stress-activated protein kinase/c-Jun N-terminal kinase in osteoblast-like MC3T3-E1 cells.

  2009cites this paper
• Different expression patterns of organic anion transporting polypeptides in osteosarcomas, bone metastases and aneurysmal bone cysts.

  2009cites this paper
• Biology of Bone

  2009cites this paper
• Simvastatin therapy in cyclosporine A-induced alveolar bone loss in rats.

  2009cites this paper